CRANIAL NERVE PALSY IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA

被引:0
作者
INGRAM, LC
FAIRCLOUGH, DL
FURMAN, WL
SANDLUND, JT
KUN, LE
RIVERA, GK
PUI, CH
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT BIOSTAT & INFORMAT SYST, MEMPHIS, TN 38101 USA
[2] ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38101 USA
[3] ST JUDE CHILDRENS RES HOSP, DEPT RADIAT ONCOL, MEMPHIS, TN 38101 USA
[4] UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT PEDIAT, MEMPHIS, TN 38163 USA
关键词
D O I
10.1002/1097-0142(19910501)67:9<2262::AID-CNCR2820670909>3.0.CO;2-U
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Forty-five children with acute lymphoblastic leukemia or non-Hodgkin's lymphoma had cranial nerve palsy (CNP) as a complication of their disease. Twenty-two of these children had CNP initially and 23, at relapse, with or without previous hematologic relapse. Only one of the 23 patients with CNP at relapse was a long-term survivor. In contrast, 11 of the 22 children who had CNP initially survived in remission for 3+ months to 13+ years. Two factors are associated with an improved outcome for patients with CNP at diagnosis: treatment after 1979 (P < 0.004) and male gender (P < 0.01). Patients who received radiation therapy fared better than those for whom radiation was not given (disease-free survival at 2 years 53% versus 29%). The authors conclude that CNP signifies an aggressive or advanced disease requiring intensive systemic chemotherapy and that the role of irradiation should be examined for this group of patients.
引用
收藏
页码:2262 / 2268
页数:7
相关论文
共 36 条
  • [1] AMYLON M, 1988, P AN M AM SOC CLIN, V7, P225
  • [2] CHILDHOOD NON-HODGKINS LYMPHOMA - THE RESULTS OF A RANDOMIZED THERAPEUTIC TRIAL COMPARING A 4-DRUG REGIMEN (COMP) WITH A 10-DRUG REGIMEN (LSA2-L2)
    ANDERSON, JR
    WILSON, JF
    JENKIN, RDT
    MEADOWS, AT
    KERSEY, J
    CHILCOTE, RR
    COCCIA, P
    EXELBY, P
    KUSHNER, J
    SIEGEL, S
    HAMMOND, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) : 559 - 565
  • [3] AUR RJA, 1978, CANCER, V42, P2123, DOI 10.1002/1097-0142(197811)42:5<2123::AID-CNCR2820420507>3.0.CO
  • [4] 2-5
  • [5] BLEYER WA, 1985, SEMIN ONCOL, V12, P131
  • [6] BOWMAN WP, 1983, LEUKEMIA RES ADV CEL, P203
  • [7] INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    CAMITTA, B
    LEVENTHAL, B
    LAUER, S
    SHUSTER, JJ
    ADAIR, S
    CASPER, J
    CIVIN, C
    GRAHAM, M
    MAHONEY, D
    MUNOZ, L
    KIEFER, G
    KAMEN, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1539 - 1544
  • [8] 4-AGENT INDUCTION AND INTENSIVE ASPARAGINASE THERAPY FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    CLAVELL, LA
    GELBER, RD
    COHEN, HJ
    HITCHCOCKBRYAN, S
    CASSADY, JR
    TARBELL, NJ
    BLATTNER, SR
    TANTRAVAHI, R
    LEAVITT, P
    SALLAN, SE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (11) : 657 - 663
  • [9] TENIPOSIDE PLUS CYTARABINE IMPROVES OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PRESENTING WITH A LEUKOCYTE COUNT-GREATER-THAN-OR-EQUAL-TO-100X109/L
    DAHL, GV
    RIVERA, GK
    LOOK, AT
    HUSTU, HO
    KALWINSKY, DK
    ABROMOWITCH, M
    MIRRO, J
    OCHS, J
    MURPHY, SB
    DODGE, RK
    PUI, CH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (07) : 1015 - 1021
  • [10] DAHL GV, 1985, BLOOD, V66, P1110